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Mice models are an important way to understand the relation between the fetus with cleft palate and changes of maternal bioﬂuid.
This paper aims to develop a metabonomics approach to analyze dexamethasone-induced cleft palate in pregnant C57BL/6J mice
andtostudytherelationshipbetweenthechangeofendogenoussmallmolecularmetabolitesinmaternalplasmaandtheincidence
of cleft palate. To do so, pregnant mice were randomly divided into two groups. The one group was injected with dexamethasone.
On E17.5th day, the incident rates of cleft palate from embryos in two groups were calculated. The 1H-NMR spectra from the
metabolites in plasma in two groups was collected at same time. Then the data were analyzed using metabonomics methods (PCA
and SIMCA). The results showed that the data from the two groups displayed distinctive characters, and the incidence of cleft
palate were signiﬁcantly diﬀerent (P<. 005). To conclude, this study demonstrates that the metabonomics approach is a powerful
and eﬀective method in detecting the abnormal metabolites from mother in the earlier period of embryos, and supports the idea
that a change from dexamethasone induced in maternal metabolites plays an important role in the incidence of cleft palate.
1.Introduction
Congenital cleft lip and palate (CLP) is the most common
birth defect in humans. The etiology is complicated, and it
involves genetic and environmental factors [1, 2]. Maternal
condition during pregnancy also appears to play an impor-
tant role [3]. Smoking [4–6], over intake of vitamin A [7, 8],
and deﬁciency in folic acid and Bs may increase risk for
oral clefts [9–12]. In addition, drug-induced (corticosteroid)
teratogenesis has also received some attention [13–16]. Most
studies above are based on epidemiological investigation.
As a useful model, experiments of mouse development are
used to assess the mechanism of palate defects in fetuses
resulting from exposure to the risk factors. Current strategies
to study orofacial defects focus on the related genotype
and transcription factors [17, 18]. However, the capability
of maternal detoxiﬁcation during orofacial development
is important for normal palate formation. As a result, a
fetus lacking genes associated with cleft palates still has
high risk of defect if maternal detoxiﬁcation is insuﬃcient.
[2, 19]
Metabonomics, based on the NMR spectroscopic and
multivariate statistics, can be useful for the description
and recognition of the dynamic multivariate metabolic
response of an organism to a pathological event or genetic
modiﬁcation. The 1H-NMR spectra of the bioﬂuids from an
organism contain a signiﬁcant amount of useful metabolic
information. Application of automated data reduction algo-
rithms and chemometric analysis, which is called pat-
tern recognition analysis (PR), can be competent for the
description and recognition of the dynamic multivariate
metabolism. It is included two major approaches, one is
termed “unsupervised”, which could be used to not only
reduce the complex and volume data to a suitable level
but also screen for the outlier and examine condition
of the clusters, including Principal Component Analysis
(PCA), Nonlinear Mapping (NLM) and Hierarchical Cluster
Analysis (HCA). The other is termed “supervised” that2 Journal of Biomedicine and Biotechnology
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Figure 1: Photos of fusion or lack of fusion by embryonic palatal shelves. The fusion situation of embryonic palatal shelves was observed
andphotographed.(a)Fusedembryonic palatalshelf.(b)Nonfusedembryonic palatalshelf.(c) Fusedembryonic palatal shelfin histological
section. (d) Nonfused embryonic palatal shelf in histological section.
means, make a mathematical model by a training set of
known class from the samples and then draw the estimated
or predictive model by independent validation set. There
are many methods such as Soft Independent Modeling of
Class Analogy (SIMCA), Partial Least Squares (PLS), Linear
discriminant analysis (LDA), K-nearest neighbor analysis
(KNN), and Bayesian methods. These approaches have been
successfully applied to study diseases and toxic processes
[20–27]. Principal component analysis (PCA) as a bilinear
decomposition method is one of the most easy and eﬃcient
approaches to analyze the NMR data, A PCA model can
trustily display a summary of all samples in the data table
[27]. Combination with using a prediction model, such as
SIMCA, can be constructed to analyze the unknown samples
[28–30].
Development of the mammalian palate involves a num-
ber of critical steps: growth, elevation, contact, and fusion
(the medial edge epithelium disappearance). Any problem
arising from these steps can lead to the incidence of cleft
palate. DEX, one of the glucocorticoids (GC), can penetrate
the blood-placental barrier and bind to GC receptor (GR)
in the cytoplasm, and can depress the ability of palatal
mesenchymal proliferation. Since the palate is smaller,
development of bilateral palates is interrupted, which results
in the cleft [31–34]. We hypothesized that the metabonomic
method could provide the framework for the studies on
the consequences of maternal environmental changes during
pregnancy and for illustrating the relationship between
the changes of maternal environment and development
of palates. To test this hypothesis, we studied the plasma
samples from pregnant C57BL/6J mice, which were induced
with dexamethasone (DEX) to trigger cleft palate formation
in the fetuses. The analyses demonstrated the relationship
between the change in endogenous small molecular metabo-
litesofmaternalplasmaandtheincidenceofcleftpalate(CP)
in fetuses.
2.MaterialsandMethods
2.1. Animal Handling and Dosing. All animal experimenta-
tion was approved by the Animal Research Committee of
theWestChinaCollegeofStomatology(SichuanUniversity).
C57BL/6J (C57) mice, about 8 weeks of age, were obtained
from the Laboratory Animal Center of Sichuan University.
All mice were reared in plastic cages (28cm × 16cm ×
12cm), under a 12/12-hour light/dark cycle. The room was
maintained at a controlled ambient temperature of 20–
27
◦C with 40%–70% relative humidity. A commercial diet
(Laboratory Animal Center of Sichuan University, China)
and tap water were fed ad libitum. Mice were allowed to
acclimatize for 48 hours prior to mating. Two virgin females
andonemalewereplacedovernightinacageandcheckedon
following morning for the copulatory plug of female mice.
Females with copulation plugs were weighed immediately
and the date was designated to Embryonic day 0(E0).
Pregnant mice (42) were randomly divided into two
groups (the experimental group and the control groupeach
group 21 mice). From the 10th day to the 12th day of preg-
nancy (From E10 to E12), the mice in the experimental group
were intraperitoneally injected daily with Dexamethasone
(DEX dexamethasone sodium phosphate injection, Tianjing
China) at 6mg/kgand while the others in the control groupJournal of Biomedicine and Biotechnology 3
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Figure 2: 600MHz 1H-NMR spectra of plasma samples from the pregnant mice in two groups: “a” showed the spectrum from one sample
in the control group; “b” showed the spectrum from one sample in the DEX group.
with isotonic sodium chloride (0.9% NaCl). The dose levels
were based on the literature report [35].
2.2. Sample Collection. On the day of E17.5, all the pregnant
mice were sacriﬁced and weighed. The peripheral blood was
placed in a lithium heparin tube (Vacuette Austria) imme-
diately. Within 2 hours of the collection, the erythrocytes
were separated by centrifugation (3000×ga t4 ◦C or 10min)
to pick up the bioﬂuid top of the plasma for analysis. All
the plasma samples were stored at −80
◦C before the 1H-
NMR analysis. At the same time, a stereomicroscope was
used to determine the number of live fetuses and gross
malformations.
2.3. Statistical Analysis of the Incidence of Cleft Palate.
After removal of the mandibles, embryonic palates were
calculated using stereomicroscope (10×)b ym o r p h o l o g i c
in two groups. Target palates were processed into paraﬃn
wax. Histological sections of embryonic palates were cut and
stained with haematoxylin and eosin (HE). The results were
photographed by a Leica photographic system (Germany).
The numbers of CP in two groups were analyzed to detect
the diﬀerent incidence rates by using chi-square test and
variance-based statistical algorithm (SPSS 10.0).
2.4. Preparation of Plasma Samples for 1H-NMR Spectroscopy.
The 1H-NMR spectra were obtained immediately after each
sample was thawed at 300K and then kept at the same
temperature in a Bruker Avance II 600 spectrometer (Bruker
Biospin,Germany),whichwasoperatingat600.13MHzwith
a 5-mm PATXI probe. In order to obtain a deuterium lock
signal for the NMR spectrometry, 200μl aliquots of all the
plasma were diluted up to 500μl with 300μlo fD e u t e r i u m
oxide (D2O).
2.5. Acquisition of 1H-NMR Spectra of Plasma. The spec-
trum was obtained by using two diﬀerent pulse sequences:
one is selective presaturation pulse sequence (Bruker
Biospin, Germany) for water suppression (located in
δ 4.8ppm) and other is CPMGPR1D pulse sequence (Bruker
Biospin, Germany). The later one, which was used to attenu-
ate the broad protein signal in the plasma, is a modiﬁcation
of the Carr-Purcell-Meiboom-Gill pulse sequence (CPMG-
pulse, Bruker Biospin Germany) to suppress the residual
water signal. For each sample, 1D 1H-NMR spectrum was
collected with 64K data points, 64 scans and 15ppm spectral
width. Other acquisition parameters were 5s relaxation
delay, 8dummy scans, 400μs ﬁxed echo time to allow the
elimination of J-mod, and 400 CPMG loops for T2 ﬁlter.
The phase and the baseline of all acquired NMR spectra were
manually calibrated, and the chemical shifts corrected by the
reference of the lactate doublet at δ1.32 [36] with TopSpin
1.3 (Bruker Biospin, Germany).
2.6. Reduction of the NMR Spectral Data. All signals of the 42
samples’ were located in the range of δ 0–7ppm in spectral
region and have no visible resonance peak after δ 7ppm.
Using MestReC (version 4.8.1.1, Spain), each 1H-NMR spec-
trumwasdividedwithδ 0.04ppmwidthinto162contiguous
segmentsandintegratedfromtherangofδ 0–7ppm[37,38].
The region of the spectrum (δ 5.0–4.5ppm) was removed
to exclude the inﬂuence of the water signal. The result was
set up to a kind of 2D matrix (n × d), “n” representing
the 42 samples, “d” meaning 162 contiguous segments.
The matrix data were normalized to the unit area with
the appropriate weighting coeﬃcients in Excel (Microsoft
USA) and then exported into the SIMCA-P software package
(version11.0, Umetrics AB, Ume˚ a, Sweden). The average
valueof eachvariable wascalculatedandsubtractedfromthe
data.4 Journal of Biomedicine and Biotechnology
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Figure 3: The plot of PCA analysis from two groups. “” showed the data from pregnant mice with CP fetuses in DEX group; “” showed
the data from pregnant mice with fusion fetuses in control group. “∗” showed the pregnant mice including CP fetuses in the control group.
Table 1: Comparison of the incidence of cleft palate in the embryos between two groups.
Non-Fusion Fusion Total Incidence of non-fusion (%)
Control group 3 103 106 2.83
DEX group 27 96 123 21.95
∗
Total 30 199 229 13.10
∗Signiﬁcant diﬀerence with respect to control (χ2 = 18.285, P<. 005).
2.7. Statistical Analysis of the Data from NMR Spectra. After
the average value being calculated from each variable and
subtracted from the data, PCA was applied to the mean-
centered data to detect the diﬀerences among the samples.
SIMCAwasperformedtovalidatetheresults.Firstly,separate
PC models were built for the training sets of 10 samples from
DEX group with CP fetuses and 10 samples including only
normalfetusofcontrolgroupandweredeﬁnedtwodistances
against boundaries (cross-validation) by the 95% conﬁdence
interval. As a typically visualizing method, the Cooman’s
plot was often used to display the result [39]. SIMCA
formulated a PC model for each distinct class and estimated
its performance. Secondly, the procedure was repeated for all
samples (the test sets) in turn, to predict and assess whether
samples were separated into two classes. Finally, the result of
the Cooman’s plot illustrated the visible separation of two
groups. Each step was repeated ﬁve times in order to keep
the validation set.
3. Results
3.1. The Statistics of the Incidence of Cleft Palate in Two
Groups. Forty-two C57BL/6J pregnant mice were examined,
and 229 fetuses were collected, including 123 fetuses from
DEXtreatmentgroupand106fetusesfromthecontrolgroup
(Table 1). Each pregnant mouse had multiple fetuses. There
was at least one CP fetus in each pregnant mouse in DEX
treatment group (named DEX group), while there were 3CP
fetuses in two pregnant mice of the control group (named
the control group with CP). The incidence of CP in the DEX
treatment group was 21.95%, signiﬁcantly diﬀerent from the
control group (P<. 005). The character of morphology and
histology were recorded (Figure 1). “a” and “c” show fusion
of palate shelves, while “b” and “d” show a failure of the
palate shelves to fuse.
3.2. 1H-NMR Spectra from Two Groups. The 1H-NMR spec-
trum of the plasma from pregnant mice revealed great
complexity and signiﬁcant information about the bioﬂuid
(Figure 2). The chemical shift of δ 4.8 was the water signal.
The regions of the signiﬁcant metabolite signals usually
ranged δ 0–4.5ppm, including alkene (δ 4–5.5ppm), alkyne
(δ 1.8–3.5ppm), and the aliphatic series (δ 0–2.8ppm).
Articles of the locations of diﬀerent chemical groups and
some low-molecular-weight metabolites had already been
published [36, 40]. To detect the diﬀerence between the
two groups, special software was used in the chemometric
analysis.
3.3. PCA of the Plasma in the DEX Group and the Control
Group. The matrix data from the 1H-NMR spectra were
exported into the SIMCA-P software and processed by PCA.
The new principal component (PC) variables were created (6
new contributories of the PCs), which accounted for 84.8%
of the original data and each PC was orthogonal with all
the other PCs. The result of PCA could be shown (Figure 3)
as the clustering of the individual dataset deﬁned by the
95% Hotelling’s T2 Limit. Except for two control samples
(∗: the blue star), all the 21 DEX samples (: the black
triangles) and 19 control samples with fusion fetuses (: the
open squares), obviously, were separated well along the ﬁrst
principal component. It indicated that the major diﬀerence
between the two groups occurred in the ﬁrst two principalJournal of Biomedicine and Biotechnology 5
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Figure 4: The plots of PCA analysis for two control pregnant mice including CP fetuses in diﬀerent groups “a” showed the PCA analysis
between two outliers from the control group and the data of pregnant mice with CP fetuses in DEX group; “b” showed the PCA analysis
between two outliers from the control group and the data of pregnant mice with no-CP fetuses in control group.
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Figure 5: The Cooman’s plot of two groups in test set from SIMCA. “” showed the DEX group with CP fetuses; “” showed the control
group with fusion fetuses; “∗” showed two outlier samples (pregnant mice with CP fetuses in control group); the red lines indicate the
D-Crit (0.05) level; two groups were located in two diﬀerent spaces; the outliers not belong to either group.
components. The detailed diﬀerent biochemical changes
were informed by the loadings (Table 2) .I no r d e rt od e t e c t
the outliers, the two outliers as one group to be detected
with Dex group and control group respectively. PCAs were
repeated twice again using diﬀerent groups (Figure 4). The
result indicated that the two outliers with CP fetuses have
some extent diﬀerent from the control group, while mixed in
the Dex-injected group because of CP fetuses.
3.4. SIMCA of the Plasma in the DEX Group and the Control
Group. The result of SIMCA was shown in the Cooman’s
plot (Figure 5). All the samples had been tested with an
independent model made of train set. The condition of
samples can be classiﬁed in a pair of distances against
boundaries(redlines)fornon-fusiondatainDEXgroupand
fusiondataincontrolgroup.Theplotcontainedfourregions
separated by 95% conﬁdence limits in a 2D graph in which
samples below the horizontal line belonged to the control
group with fusion fetuses (95%), while samples in the left
region of the vertical line belonged to DEX group with CP
fetuses (95%). The data from control group with CP fetuses
(the outliers) neither belongs to DEX group nor belongs
to control group. It demonstrated that plasma classes from
pregnant mice with CP fetuses and normal control did not
share the same space. Therefore, this model should be able to
predict whether maternal environment has been aﬀected by
DEX or not.
4. Discussion
In the normal mouse embryo, palate shelves grow and
elevateintoahorizontalpositionbyembryonicday14(E14).
By the day of E17, the process of fusion has completely
ﬁnished. We chose to collect samples on E17.5 for the
following reasons. It was convenient to use morphology
for embryo analysis, and it was easy to display the change
of maternal metabolism without the inﬂuence of DEX
[41]. Furthermore, another study also proved that the
spectra of plasma from Dex-injected and control male mice
showednosigniﬁcantdiﬀerenceduringdiﬀerenttimeframes6 Journal of Biomedicine and Biotechnology
Table 2: the main metabolites changes that were partially responsi-
ble for discriminating Dex group from control using PCA.
1H bucket region (δ) metabolites Changes in Dex group
1.32, 4.12 Lactate ↑
∗
1.36 unknown ↑
1.48 Alanine CH3 ↑
1.72 Arginine(γ-H) ↓
1.92 Arginine (β-H) ↓
2.02 Acetate ↑
2.04 Lipid CH2CH2CH=CH ↑
2.12 Glutamine ↑
2.28 Valine (β-H) ↓
2.36 Glutamate ↑
2.4801 unknown ↑
2.5201 Lipid –C=C–CH2–C=C ↓
2.8 Aspartic acid (β-H) ↓
3.24 Choline N (CH3)3+ ↑
3.64 Valine (α-H) ↓
3.92 Creatine ↑
4.04 myo-inositol ↓
∗↑, relative increase in signal by loading plot.
(2 hours, 1 day, 2 days, 3 days, and 7 days). The PCAs also
show that all data from diﬀerent time frames were a mixture
together, which accounted for 89.9% from the original data
(supplement).
Diﬀerent murine strains also have diﬀerent suscepti-
bilities to the DEX-induced cleft palate. The incidence in
our model was in accord with previous work [42]. Some
studies indicate [43–45] that the incidence of cleft palate
may be closely related to high maternal concentration of
plasma homocysteine or lower activity of the glucocorti-
coids prereceptor metabolizing enzyme11β-hydroxysteroid
dehydrogenasetype2(11β2HSD2)inplacentaltrophoblastic
cells. However, the exact mechanisms by which interaction
between maternal environment and DEX causes teratogenic
eﬀects are poorly understood. NMR spectroscopy-based
metabonomic approach oﬀers a unique opportunity to focus
on the relationship between genotype and phenotype and
is especially suited to uncover changes in drug-induced
metabolites [46, 47]. In this study, each mother at least
has one CP fetus in DEX-injected group. Some changes of
maternal metabolites informed us about the abnormality of
the embryo. Therefore, the result from two groups displayed
the diﬀerent metabolites between CP fetus and fusion one.
From the spectra of 1H-NMR (Figure 2), we can see clearly
some diﬀerences between the samples of the two groups
within the range of chemical shift from δ 1.8 to δ 3.5ppm
and the range of glucose and amino acid CH. The PCA plots
showed good separation of the two groups except for two
control samples (Figure 3), which matched the results from
morphologic analysis identifying three cleft palate fetuses
from two diﬀerent individual mice in the control group. In
order to analyze the outlier from the control group, the two
outliers as a group were analyzed again. The result also show
these two samples were closely blended in the DEX group
(Figure 4(a)),whilefarawayfromthecontrols’(Figure 4(b)).
Some biochemical changes such as decrease of Arginine
(1.72, 1.92ppm), increase of Alanine (1.48ppm), N-acetyl
glycoprotein (2.12ppm), Choline (3.24ppm), and Creatine
(3.92ppm) may response to the change of methyl group
metabolism in maternal environment. The key donor of
methylation is S-adenosyl methionine (SAM) which comes
from methionine. Arginine and Creatine may increase ATP
to supply the circle from methionine to homocysteine [48].
Normally, the incidence of cleft palate in C57BL/6J natural
mice is zero. The reason may be that we injected isotonic
sodium chloride (0.9% NaCl) in control samples in order
to keep the same stimulating circumstance as in the DEX
group. After SIMCA analysis, the result of the Cooman’s
plot revealed a good ﬁt model to detect the NMR data and
separate the CP group from the controls by using a test set of
F-statistic. Both plots clearly showed a relationship between
the fetus’ cleft palate and the plasma metabolic proﬁle of
the mother. In conclusion, this study provides evidence that
metabonomic method is suﬃciently sensitive to detect small
diﬀerencesinthecomposition ofmaternalbioﬂuids andmay
be helpful for identifying biomarkers of teratogenesis.
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